NIH
-
VICC researchers to study reasons for high breast cancer incidence and mortality rates among African-American women
A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women. Read MoreJul 6, 2016
-
Vanderbilt establishes Recruitment Innovation Center to increase enrollment of minorities, women and older adults in clinical trials
Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this. Read MoreJul 5, 2016
-
A little spark for sharper sight
Stimulating the brain with a mild electrical current can temporarily sharpen vision without glasses or contacts, Vanderbilt University researchers have found. (But please don't try this at home.) Read MoreJun 30, 2016
-
The odds of asthma
A number of factors during infancy increase the risk that a child will later develop asthma. Read MoreJun 27, 2016
-
Superior scan for tumors
Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors. Read MoreJun 24, 2016
-
It takes two to tango: beta cell development
Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes. Read MoreJun 23, 2016
-
Drug monitoring programs reduce opioid deaths: study
The implementation of state prescription drug monitoring programs was associated with the prevention of approximately one opioid-related overdose death every two hours on average nationwide, according to a new Vanderbilt-led study released this week in the journal "Health Affairs." Read MoreJun 23, 2016
-
President nominates Hiebert for National Cancer Advisory Board
President Barack Obama has nominated Scott Hiebert, Ph.D., professor of Biochemistry and associate professor of Medicine, to serve as a member of the National Cancer Advisory Board (NCAB). Read MoreJun 21, 2016
-
Uninsured heart attack patients more likely to be transferred to another facility: study
A new study finds that uninsured heart attack patients are more likely to be transferred. Read MoreJun 9, 2016
-
Pulmonary fibrosis culprits
New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease. Read MoreJun 6, 2016
-
Pregnancy-related heart disorder clues
Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure. Read MoreJun 3, 2016
-
‘Crowdsourcing’ project aims to refine data extraction from electronic health records
A research team at Vanderbilt University Medical Center (VUMC) will develop a crowdsourcing solution for generating a wide range of labeled data sets from electronic health records (EHRs). Read MoreJun 2, 2016
-
NIH awards $11.6 million grant to Vanderbilt, Miami and Meharry for new center to study precision medicine and health disparities
Researchers at Vanderbilt University Medical Center (VUMC), the University of Miami and Meharry Medical College were recently awarded a five-year, $11.6 million grant to launch a new center that will enable research using precision medicine to eradicate health disparities, specifically those among African-Americans and Latinos. Read MoreMay 25, 2016
-
New center to study genomic privacy concerns
Researchers at Vanderbilt University School of Medicine have received a four-year, $4 million grant from the National Institutes of Health (NIH) to establish a new center for the study of privacy concerns associated with the use of genomic information, the NIH announced this week. Read MoreMay 19, 2016
-
New pain medicine from a fungus?
Collybolide – a natural product isolated from a mushroom – is a promising candidate for the development of non-addictive pain medicines. Read MoreMay 13, 2016
-
COX-2 blocker could help PTSD
COX-2 inhibitors – used clinically to reduce inflammation and pain – may find new applications for treating PTSD and other stress-related psychiatric disorders like major depression. Read MoreMay 12, 2016
-
Improving natural killer cancer therapy
A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies. Read MoreApr 29, 2016
-
An Argonaute’s voyage to cancer
A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.” Read MoreApr 28, 2016
-
Investigators explore African ancestry, Alzheimer’s risk
Higher genomic levels of African ancestry are associated with an increased risk for Alzheimer’s disease, a consortium of investigators reported recently in Alzheimer’s & Dementia. Read MoreApr 28, 2016
-
Scientists establish first map of the sea lion brain
A team of neuroscientists at Vanderbilt University has taken an important step toward uncovering the mystery behind the California sea lion's prodigious intelligence by conducting the first comprehensive study of their central nervous systems. Read MoreApr 27, 2016